Similar articles

• Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7 to 9 December 2011.

  Ampofo WK, Al Busaidy S, Cox NJ, Giovanni M, Hay A, Huang S, Inglis S, Katz J, Mokhtari-Azad T, Peiris M, Savy V, Sawanpanyalert P, Venter M, Waddell AL, Wickramasinghe G, Zhang W, Ziegler T; WHO Writing Group. Ampofo WK, et al. Vaccine. 2013 Jul 11;31(32):3209-21. doi: 10.1016/j.vaccine.2013.05.049. Epub 2013 May 17. Vaccine. 2013. PMID: 23685246 No abstract available.
• The protection of ferrets against influenza by immunization with a split influenza vaccine.

  Brady MI, Furminger IG. Brady MI, et al. Dev Biol Stand. 1975;28:167-72. Dev Biol Stand. 1975. PMID: 1126566
• Antigenic relationships among influenza virua A neuraminidase (N2) antigens by immunodiffusion and postinfection neutralization tests.

  Dowdle WR, Laver WG, Galphin JC, Downie JC. Dowdle WR, et al. J Clin Microbiol. 1976 Mar;3(3):233-8. doi: 10.1128/jcm.3.3.233-238.1976. J Clin Microbiol. 1976. PMID: 57967 Free PMC article.
• Relationship between the H and N antigens of A/Hong Kong/68 and Q/England/42/72 influenza viruses as determined in naturally infected and vaccinated individuals.

  Závadová H, Vonka V, Domoázkova E, Brůjs F. Závadová H, et al. J Biol Stand. 1975;3(1):35-9. doi: 10.1016/0092-1157(75)90005-0. J Biol Stand. 1975. PMID: 1126960 No abstract available.
• Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.

  Monto AS, Petrie JG, Cross RT, Johnson E, Liu M, Zhong W, Levine M, Katz JM, Ohmit SE. Monto AS, et al. J Infect Dis. 2015 Oct 15;212(8):1191-9. doi: 10.1093/infdis/jiv195. Epub 2015 Apr 8. J Infect Dis. 2015. PMID: 25858957 Clinical Trial.